PCSK9-IN-3
Product Specifications
CAS Number
2867496-34-0
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/pcsk9-in-3.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CC[C@H](OC/C=C/CC2=CC=CC(C[C@H](NC([C@@H](C)NC([C@@H](NC(CCSC3)=O)CNC(CCOCCOCC[N+](C)(C)C)=O)=O)=O)C(N4)=O)=C2)[C@H]1C(N[C@H](C(N[C@H]5CC6=CC=C(OC)C=C6)=O)[C@@H](C)O)=O)[C@@H]4CC7=CN(CC8=CN(C9=CC3=CC(CSCCNC([C@]%10(C)CCCN%10C5=O)=O)=C9)N=N8)C%11=C7C=C(F)C=C%11.[O-]C(C(F)(F)F)=O
Molecular Weight
1724.94
References & Citations
[1]Tucker TJ, et al. A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors. J Med Chem. 2021 Nov 25;64(22):16770-16800.
Shipping Conditions
Room temperature
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP306935 20 µg
CuLlin 4B (CuL4B) (NM_003588) Human Recombinant Protein
Sign In for Pricing
View Details 
LC403481 20 µg
GCOM1 (MYZAP) (NM_152451) Human Over-expression Lysate
Sign In for Pricing
View Details 